FameEX 加密货币每日晨报新闻丨8月9日, 2024

币界网Publicado em 2024-08-09Última atualização em 2024-08-09

币界网报道:

美联储缩表即将结束,具体降息时间或取决于市场压力

据报道,美联储即将结束缩表,降息的具体时间或取决于降息步伐和和融资市场压力。决策者暗示将在年底前完成美国债务减持,但华尔街预计量化紧缩不太可能突然结束。

比特币矿工储备跌至三年来最低水平

截至 8 月 3 日,比特币矿工持币量已降至约 1,510,300 BTC,较 2020 年 12 月峰值下降 2.4%,创三年以来的新低。此外,四月份比特币减半事件显着减少了矿工收入,迫使他们出售更多的加密货币。

美国控制了比特币 35% 的算力

CryptoQuant 创始人兼首席执行官 Ki Young Ju 表示,美国控制着 35%  的比特币算力。与此同时,俄罗斯似乎正在采取行动跟上美国的步伐,国家层面的 FOMO 情绪正在升温。

美国就业数据提振市场情绪

美国就业市场表现强劲,推动了美国股市的上涨。这主要源自于美国申请失业救济的人数少于预期,缓解了市场对经济衰退的担忧。不过,华尔街仍持有谨慎态度,担心如果经济增长继续放缓且美联储不紧急放松货币政策,那么,美股可能会面临更大的下行风险。

Greeks.live:加密货币跌势暂停,市场显示出了复苏迹象

Greeks.live 宏观研究员 Adam 在 X 平台发帖表示,近期日本央行的鹰派言论对加密货币价格产生了重大影响。他强调说有必要监控日本央行在本月的行动,因为日元在全球宏观交易中发挥着至关重要的作用。加密货币上周的大幅跌势已经停止,市场正在复苏,所以各主要期限 IV 有所回落。

普京签署俄罗斯加密货币开采合法化法案

据塔斯社报道,8 月 8 日,俄罗斯总统弗拉基米尔・普京签署了一项法律,使俄罗斯的加密货币挖矿正式合法化。

免责声明:本节提供的信息仅供参考,不代表任何投资建议或 FameEX 官方观点。

Leituras Relacionadas

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

On August 10, 2026, BPL (300246.SZ) resumed trading after a nearly week-long suspension and immediately fell by a 20% limit-down. This plunge was triggered by the termination of a planned controlling stake transfer, dashing earlier market speculation. In January 2026, Zhejiang Quwei Zhihe Partnership entered as a significant shareholder, sparking hopes. Investors speculated that its backer, Weigu Information—a specialized "little giant" company in high-reliability solid-state storage chips—might be seeking a backdoor listing through BPL. This "cross-industry restructuring" expectation fueled a strong rally, with BPL's stock price more than doubling in 2026 prior to the halt. However, the deal was called off on August 7, directly causing the sharp sell-off. Underlying BPL's vulnerability is its fundamentally weak business. The company, a medical device firm, is mired in losses, having reported three consecutive years of net losses totaling over 200 million yuan. Its core hemodialysis business is squeezed by government procurement price cuts, while growth in its patient monitor segment has stalled. Furthermore, BPL faces imminent debt pressure with convertible bonds worth approximately 218 million yuan due in September 2026, and its current stock price is far below the conversion price. The failed control transfer may represent a delayed release of negative news, but BPL's core challenges remain: reversing operational losses and addressing its urgent liquidity crisis.

marsbitHá 58m

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

marsbitHá 58m

Trading

Spot
活动图片